Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma.

The Journal of Biological Chemistry
A L BiereD Selkoe

Abstract

The amyloid beta-peptide (Abeta) is the major constituent of neuritic plaques in Alzheimer's disease and occurs as a soluble 40-42-residue peptide in cerebrospinal fluid and blood of both normal and AD subjects. It is unclear whether Abeta, once it is secreted by cells, remains free in biological fluids or is associated with other proteins and thus transported and metabolized with them. Such knowledge of the normal fate of Abeta is a prerequisite for understanding the changes that may lead to the pathological aggregation of soluble Abeta in vivo, the possible influence of certain extracellular proteins, particularly apolipoprotein E, on plaque formation, and the pharmacology of putative Abeta-lowering drugs. To address the question of Abeta distribution in human biological fluids, we incubated fresh human plasma from 38 subjects with physiological concentrations (0.5-0.7 nM) of radioiodinated Abeta1-40 and seven plasma samples with Abeta1-42. Lipoproteins and lipid-free proteins were separated and analyzed for bound iodinated Abeta1-40. We found that up to 5% of Abeta added to plasma is bound to selected lipoproteins: very low density, low density, and high density, but not lipoprotein(a). The large majority ( approximately 89%...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·P S RoheimG L Vega
Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J E MaggioP W Mantyh
May 1, 1989·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·A SteinmetzH Kaffarnik
Jan 1, 1986·Methods in Enzymology·J L Kelley, A W Kruski
Sep 1, 1986·The Journal of Clinical Investigation·R E GreggH B Brewer
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Nov 9, 1995·The New England Journal of Medicine·T PolvikoskiK Kontula
Nov 9, 1995·The New England Journal of Medicine·B T Hyman, R Tanzi
May 1, 1995·Nature Genetics·H Funke, G Assmann
Apr 21, 1995·The Journal of Biological Chemistry·M J LaDuM T Falduto
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·M CitronD J Selkoe
Jan 1, 1994·Acta Neuropathologica·H M Wisniewski, J Wegiel
Dec 30, 1993·Biochemical and Biophysical Research Communications·B V ZlokovicB Frangione
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·D E SchmechelA D Roses
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J BusciglioB A Yankner
Apr 30, 1993·Biochemical and Biophysical Research Communications·T WisniewskiB Frangione
Feb 1, 1996·Journal of Neurochemistry·W P EslerJ E Maggio

❮ Previous
Next ❯

Citations

Aug 11, 2000·Microscopy Research and Technique·G M Cole, M D Ard
Feb 19, 2000·Biochemical and Biophysical Research Communications·Y M KuoA E Roher
May 6, 2009·Journal of Neural Transmission·Andrea MarcelloThomas A Bayer
Feb 23, 2012·Journal of Neural Transmission·Robert A RissmanPaul S Aisen
Jun 11, 2008·Neuromolecular Medicine·Esther S OhStina M Fangmark Tucker
Jan 24, 2004·Biochimica Et Biophysica Acta·Lee StanyerChristopher C T Smith
Mar 7, 2001·Biological Psychiatry·H ZengM G Zagorski
Jul 30, 2003·Neurobiology of Aging·Barbara BorroniAlessandro Padovani
Jan 3, 2001·Free Radical Biology & Medicine·A KontushU Beisiegel
Nov 17, 2009·Proceedings of the National Academy of Sciences of the United States of America·Xiaoyan HuJin-Moo Lee
Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Philip B VergheseDavid M Holtzman
Jul 28, 2006·The Journal of Biological Chemistry·Adrian M IsaacsBruce A Yankner
Sep 10, 2002·Alzheimer Disease and Associated Disorders·Zoe ArvanitakisNeill R Graff-Radford
Apr 3, 2008·Current Opinion in Psychiatry·Takeshi Kawarabayashi, Mikio Shoji
Mar 17, 1999·The Journal of Clinical Investigation·D M HoltzmanS M Paul
Jul 31, 2008·PloS One·Sung-Min AhnBonghee Lee
May 20, 2011·Reviews in the Neurosciences·Kanaiyalal D PrajapatiNilanjan Roy
Apr 14, 2010·Biomarkers in Medicine·Katarzyna Gustaw-RothenbergMark A Smith
Jan 7, 2014·Molecular Neurodegeneration·Leon M TaiMary Jo LaDu
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·T Kowalewski, D M Holtzman
May 28, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Mukhtar H AhmedTia E Keyes
Sep 8, 2012·International Journal of Alzheimer's Disease·Pedro PesiniManuel Sarasa
Jan 29, 2013·Annual Review of Biochemistry·Amy R WyattMark R Wilson
May 10, 2002·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·William P EslerJohn E Maggio
Jun 18, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Hyo Jung ChoiDong Young Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.